Jim Cramer on Regeneron (REGN): “I Think The Stock’s Breaking Out Here”

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the stocks Jim Cramer discussed alongside the tech market divide. Toward the end of the lightning round, a caller sought Cramer’s thoughts on the company, and here’s what he had to say in response:

I think Regeneron, I think Leonard Schleifer’s doing an unbelievable job. I think the stock’s breaking out here, I really do. I mean, I looked at it for the Charitable Trust, that and Amgen, we bought another stock, but those are the two I really like.

A stock market data. Photo by AlphaTradeZone on Pexels

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases. A caller inquired about the stock during the March 2 episode, and Cramer replied:

Oh man, you know what? I should have pulled the trigger on Regeneron when I sat down with them at the JPMorgan conference. I realized that the Charitable Trust should have owned it. It would’ve a much better, really much better drug stock than the others that we have, with the exception of Eli Lilly.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.